Galaxy Medicare Board of Directors

Get the latest insights into the leadership at Galaxy Medicare. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Dillip Kumar Das Chairman & Managing Director
Mr. Subhasish Das Whole Time Director
Mrs. Kiran Das Whole Time Director
Mr. Soumya Mohanty Ind. Non-Executive Director
Mr. Aklant Das Ind. Non-Executive Director
Mr. Shaswat Kumar Rout Ind. Non-Executive Director

Galaxy Medicare Share price

GML

22.55

1.15 (-4.85%)
Last updated on 7 Oct, 2025 | 13:44 IST
BUYSELL
Today's High

23.20

Today's Low

22.55

52 Week Low

22.55

52 Week High

54.00

The current prices are delayed, login to your account for live prices

Galaxy Medicare FAQs

The board at Galaxy Medicare consists of experienced professionals, including Mr. Dillip Kumar Das , Mr. Subhasish Das , and others, overseeing the company’s strategic and corporate governance.

Directors at Galaxy Medicare are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Dillip Kumar Das is the current chairman at Galaxy Medicare.

Executive directors at Galaxy Medicare are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Galaxy Medicare adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Galaxy Medicare, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.